Labcorp Holdings (LH) last issued guidance on April 30, 2026 for fiscal year 2026. The company guided earnings per share in the range of $17.70 - $18.35, compared to a consensus EPS estimate of $17.76. Labcorp Holdings also guided revenue in the range of $14.65B - $14.80B for the period.
Compared to prior guidance, Labcorp Holdings maintained its EPS outlook from a previous range of $17.55 - $18.25. On the revenue side, the company maintained its revenue forecast from a prior range of $14.61B - $14.79B.
Labcorp Holdings has issued 18 guidance updates between July 28, 2022 and April 30, 2026. During this period, the company raised its outlook 5 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
Review all historical guidance issued by Labcorp Holdings, including EPS and revenue forecasts across quarterly and annual periods.
The most recent guidance for Labcorp Holdings (LH) was reported on April 30, 2026 for the fiscal year 2026. The company provided earnings per share guidance in the range of $17.70 to $18.35, compared to the estimated EPS of $17.76. Additionally, Labcorp Holdings forecasted revenue between $14.65B and $14.80B for the period.
Labcorp Holdings (LH) guided EPS in the range of $17.70 to $18.35 for the fiscal year 2026. The consensus analyst EPS estimate is $17.76.
Labcorp Holdings (LH) guided revenue in the range of $14.65B to $14.80B for the fiscal year 2026.
Labcorp Holdings (LH) maintained its EPS guidance from a prior range of $17.55 - $18.25 to $17.70 - $18.35 for the fiscal year 2026.
Labcorp Holdings (LH) last issued guidance on April 30, 2026 for the fiscal year 2026.